Global mRNA Drug Supply, Demand and Key Producers, 2023-2029

Global mRNA Drug Supply, Demand and Key Producers, 2023-2029

The global mRNA Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.

This report studies the global mRNA Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global mRNA Drug total production and demand, 2018-2029, (K Units)

Global mRNA Drug total production value, 2018-2029, (USD Million)

Global mRNA Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Drug consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: mRNA Drug domestic production, consumption, key domestic manufacturers and share

Global mRNA Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global mRNA Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global mRNA Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global mRNA Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Drug market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global mRNA Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global mRNA Drug Market, Segmentation by Type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs

Global mRNA Drug Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen

Key Questions Answered

1. How big is the global mRNA Drug market?

2. What is the demand of the global mRNA Drug market?

3. What is the year over year growth of the global mRNA Drug market?

4. What is the production and production value of the global mRNA Drug market?

5. Who are the key producers in the global mRNA Drug market?

6. What are the growth factors driving the market demand?